ERLONAT ERLOTINIB 150 Mg TABLETS

Get a Price/Quote

ERLONAT ERLOTINIB 150 Mg TABLETS Specification

Origin of Medicine
India

Indication
Treatment of advanced or metastatic non-small cell lung cancer and pancreatic cancer

Dosage Form
Oral tablet

Pacakaging (Quantity Per Box)
30 tablets

Salt Composition
Erlotinib Hydrochloride 150 mg

Drug Type
Allopathic

Ingredients
Erlotinib Hydrochloride

Physical Form
Tablet

Function
Antineoplastic (Anti-cancer)

Recommended For
Non-Small Cell Lung Cancer (NSCLC), Pancreatic Cancer

Dosage
150 mg per tablet

Dosage Guidelines
As directed by physician

Suitable For
Adults

Quantity
30 tablets per box

Storage Instructions
Store below 30C, protect from moisture and light

Color
White

Shelf Life
24 months

Prescription Required
Yes

Shape
Round

Brand Name
Erlonat

ATC Code
L01XE03

Batch Number
Printed on pack

Route of Administration
Oral

Marketed By
Natco Pharma Ltd.

About ERLONAT ERLOTINIB 150 Mg TABLETS

Erlonat 150 Mg Tablets - Erlotinib

Erlonat Tablets Contains Erlotinib And Belongs To A Class Of Medications Called Kinase Inhibitors. Erlonat Is Used For The Treatment Of Non- Small Cell Lung Cancer. Erlonat Is Used In Combination With Gemcitabine For The Treatment Of Pancreatic Cancer That Has Spread To Nearby Tissues Or To Other Parts Of The Body.

Available As : 25 Mg, 100 Mg & 150 Mg Tablets.

Specifications

Product Name - Erlonat 150 Mg Tablets
Content - Erlotinib Hydrochloride
Form - Tablets
Strength - 25 Mg, 100Mg, 150 Mg
Packing - Pack Of 30 Tablets
Manufactured By : Natco

Note:ErlonatIs A Prescription Drug And Should Be Used Under Proper Medical Guidance And Advice. Do Not Share The Medicine With Others, Since They May Be Suffering From A Problem That Is Not Effectively Treated By This Drug..............

Designed for Effective Cancer Therapy

Erlonat (Erlotinib Hydrochloride) 150 mg tablets are engineered to target cancer cells, specifically benefiting adults diagnosed with advanced NSCLC and metastatic pancreatic cancer. With precise dosage and oral administration, Erlonat helps limit tumor progression, supporting optimal outcomes under physician supervision.

Proper Usage and Safe Administration

The recommended administration route for Erlonat is oral, taken exactly as directed by your healthcare provider. Adhering to prescribed dosage and timing enhances therapeutic results while minimizing side effects. Patients should never alter their dosage without medical advice.

Advantages of Erlonat in Cancer Management

Erlonat offers significant benefits by impeding cancer cell growth and spread, which can lead to improved symptom management and extended survival for individuals facing advanced NSCLC or pancreatic cancer. This targeted approach contributes to more focused and effective treatment plans.

FAQs of ERLONAT ERLOTINIB 150 Mg TABLETS:

Q: How should Erlonat Erlotinib 150 mg tablets be taken for optimal effectiveness?

A: Erlonat should be taken orally, following the precise dosage and schedule provided by your physician. Take the tablet with water and avoid food at least one hour before or two hours after administration, unless otherwise instructed.

Q: What is the primary benefit of using Erlonat for cancer treatment?

A: The main benefit of Erlonat lies in its ability to hinder the growth and spread of cancer cells, particularly for advanced non-small cell lung cancer and metastatic pancreatic cancer, helping to improve survival rates and quality of life.

Q: When is Erlonat prescribed, and for which conditions?

A: Erlonat is prescribed for adults diagnosed with advanced or metastatic non-small cell lung cancer and pancreatic cancer, usually after assessment by a healthcare professional and when other treatment options are appropriate or indicated.

Q: Where should Erlonat tablets be stored to preserve their effectiveness?

A: Store Erlonat tablets below 30C, away from moisture and light, and always keep them in the original packaging. Proper storage ensures maintained potency throughout its 24-month shelf life.

Q: What precautions should be taken during the use of Erlonat tablets?

A: Only use Erlonat under medical supervision. Do not self-medicate, and inform your doctor of any other medications or health conditions. Report any unusual symptoms promptly and adhere strictly to dosage guidelines.

Q: Who supplies and distributes Erlonat tablets?

A: Erlonat tablets are marketed by Natco Pharma Ltd., India, and are available through authorized distributors, exporters, suppliers, traders, and wholesalers both locally and internationally.

Tell us about your requirement